Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

RARalpha-selective agonist undergoes early clinical testing in cancer patients

Nov. 28, 2001

OncoGenex and Isis collaborate on antisense drug for prostate and other cancers

Nov. 28, 2001

Active Biotech signs benzamide licensing agreement with Oxigene

Nov. 28, 2001

Antitumor and antimetastatic effects demonstrated in new series from Ishihara Sangyo

Nov. 27, 2001

AstraZeneca to return development rights for ZD-0473 to AnorMED

Nov. 27, 2001

Matrix seeks approval for IntraDose in Europe

Nov. 27, 2001

Protein tyrosine kinase inhibitors from AHP exert antitumor activity in vitro

Nov. 26, 2001

Antitumor sulfonamide derivatives reported in recent patent by Sankyo

Nov. 26, 2001

Specific inhibition of MMP-2 binding to alphavbeta3 integrin for inhibiting angiogenesis

Nov. 26, 2001

Design and biological activity of new camptothecin glycoconjugates described by Bayer

Nov. 26, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.